文献速递主动脉疾病

男性一次性腹主动脉瘤超声筛查短期与长期有效性的系统评价

A systematic review of short-term vs long-term effectiveness of one-time abdominal aortic aneurysm screening in men with ultrasound.
PubMed 文献 · J Vasc Surg · 2018-01-01

该系统评价基于四项人群随机对照试验的汇总数据,评估男性一次性腹主动脉瘤超声筛查的短期(随访3-5年)与长期(随访13-15年)有效性。结果显示筛查可显著降低腹主动脉瘤相关死亡率和破裂率,且长期随访仍获益;全因死亡率短期无显著影响,长期边缘显著。

要点

  • 男性一次性腹主动脉瘤超声筛查短期随访腹主动脉瘤相关死亡率降低43%(RR 0.57,95%CI 0.44-0.72),长期降低34%(RR 0.66,95%CI 0.47-0.93)。
  • 筛查短期随访腹主动脉瘤破裂率降低48%(RR 0.52,95%CI 0.35-0.79),长期降低35%(RR 0.65,95%CI 0.51-0.82)。
  • 全因死亡率短期无显著影响(P=0.14),长期边缘显著(RR 0.99,95%CI 0.98-1.00,P=0.03)。

核心结论

  • 对65岁及以上无症状男性进行人群基础的一次性腹主动脉瘤超声筛查在筛查停止后的较长时期仍有益处,显著降低腹主动脉瘤死亡率和破裂率,从而避免不必要的腹主动脉瘤相关死亡。
  • 敏感性分析显示,筛查的获益在平均年龄<70岁且腹主动脉瘤患病率相对较低的男性中比在平均年龄>70岁且患病率相对较高的男性中更为明显。
  • 未来研究应探索基于年龄、性别、吸烟状况、家族史、主动脉直径和基线破裂风险等危险因素的靶向筛查方法的长期益处。

研究设计与样本

  • 系统评价,纳入来自最新美国预防服务工作组腹主动脉瘤筛查综述的研究,并筛选截至2017年4月的检索文献(PROSPERO注册号CRD42015019047)。
  • 基于四项人群基础随机对照试验的中等质量证据进行汇总估计。

主要发现

  • 短期随访(3-5年)中,一次性腹主动脉瘤筛查使腹主动脉瘤相关死亡率降低43%(RR 0.57,95%CI 0.44-0.72;需筛查人数796),腹主动脉瘤破裂率降低48%(RR 0.52,95%CI 0.35-0.79;需筛查人数606)。
  • 长期随访(13-15年)中,一次性腹主动脉瘤筛查使腹主动脉瘤相关死亡率降低34%(RR 0.66,95%CI 0.47-0.93;需筛查人数311),腹主动脉瘤破裂率降低35%(RR 0.65,95%CI 0.51-0.82;需筛查人数264)。
  • 全因死亡率在短期随访中无显著影响(P=0.14),在长期随访中边缘显著(RR 0.99,95%CI 0.98-1.00;P=0.03;需筛查人数164)。
  • 一次性腹主动脉瘤筛查与择期腹主动脉瘤相关手术数量显著增加相关,随后在短期和长期随访中急诊腹主动脉瘤手术数量和术后30天死亡率均降低。
  • 与对照组相比,一次性腹主动脉瘤筛查在择期和急诊手术导致的术后30天死亡率方面无差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: An up-to-date systematic review on the long-term benefits of one-time abdominal aortic aneurysm (AAA) screening in men with ultrasound is required as new evidence is available. This report was produced for the Canadian Task Force on Preventive Health Care to provide evidence on screening for AAA with ultrasound. The aim of this systematic review was to examine the short-term (3-5 years of follow-up) vs long-term (13-15 years of follow-up) effectiveness of one-time screening for AAA in men. METHODS: This systematic review considered studies from the most recent U.S. Preventive Services Task Force review on AAA screening and passed through the screening process with citations identified in our search up to April 2017 (PROSPERO registration #CRD42015019047). RESULTS: Based on pooled estimates from four population-based randomized controlled trials with moderate-quality evidence, one-time AAA screening in men showed significant reductions in AAA-related mortality and AAA rupture rate, with a reduction of 43% for AAA-related mortality (risk ratio [RR], 0.57; 95% confidence interval [CI], 0.44-0.72; number needed to screen [NNS], 796) and 48% for AAA rupture rate (RR, 0.52; 95% CI, 0.35-0.79; NNS, 606) in short-term follow-up and a reduction of 34% for AAA-related mortality (RR, 0.66; 95% CI, 0.47-0.93; NNS, 311) and 35% for AAA rupture rate (RR, 0.65; 95% CI, 0.51-0.82; NNS, 264) in long-term follow-up. The effect on all-cause mortality was nonsignificant (P = .14) for short-term follow-up but marginally significant for long-term follow-up (RR, 0.99; 95% CI, 0.98-1.00; P = .03; NNS, 164). One-time AAA screening in men was also associated with a significant increase in the number of elective AAA-related procedures and a subsequent decrease in the number of emergency AAA procedures and 30-day postoperative mortality at both short-term and long-term follow-ups. We found no differences for one-time AAA screening in 30-day postoperative mortality due to elective and emergency operations compared with control groups. CONCLUSIONS: Population-based one-time screening for AAA with ultrasound in asymptomatic men aged 65 years and older remains beneficial during the longer term after screening has ceased, with significant reductions in AAA mortality and AAA rupture rate, and hence avoids unnecessary AAA-related deaths. The sensitivity analyses also showed that the benefits of AAA screening were more pronounced in men at a mean age of <70 years with a relatively lower prevalence of AAA than in men at a mean age of >70 years with a relatively higher prevalence of AAA. Future research should explore the long-term benefits of a targeted AAA screening approach based on risk factors such as age, sex, smoking status, family history, aortic diameter, and baseline risk of rupture.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Ali MU, Fitzpatrick-Lewis D, Kenny M, et al. A systematic review of short-term vs long-term effectiveness of one-time abdominal aortic aneurysm screening in men with ultrasound. J Vasc Surg. 2018. PMID: 30037679. doi:10.1016/j.jvs.2018.03.411

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。